Bayer's Shares Teeter on the Edge as a Legal Reckoning and a Geopolitical Squeeze Near

Bayer stock hovers near 200-day moving average as CEO warns of Supreme Court glyphosate ruling, Strait of Hormuz fertilizer trade risk, and high German cost disadvantages.

The stock of German pharmaceutical and agrochemical giant Bayer closed the week at €35.95 — a hair’s breadth above its 200-day moving average of €35.80, a level technicians watch as a proxy for the long-term trend. That 0.41 percent gap is thin protection. The 50-day and 100-day averages at €38.39 and €40.50 respectively show the shares are lagging well behind their intermediate momentum. The relative strength index of 42.6 suggests neither panic nor power. Yet the real story is not found on any chart. It is a collision of three forces: a looming US Supreme Court judgment, a potential choke point for global fertilizer supplies, and a CEO who is openly frustrated with his home market.

Chief executive Bill Anderson used a recent interview to flag a threat to Bayer’s agricultural division that is as indirect as it is dangerous. Roughly a third of the world’s trade in nitrogen-based fertilizer passes through the Strait of Hormuz, he noted. If that waterway remains blocked, harvests in the northern hemisphere could shrink significantly as early as this autumn. Bayer does not make fertilizer itself, but farmers hit by lower yields buy less seed — a direct hit to the Crop Science unit’s core business. Anderson also warned that a knock-on maize shortage would tighten animal feed supplies, pushing up the price of meat and eggs.

While that geopolitical risk simmers, Bayer’s legal overhang is moving toward a moment of clarity. The US Supreme Court heard oral arguments on April 27 in a pivotal glyphosate case, and a decision is expected by the end of June. The justices appeared split. A ruling that reinforces federal pre-emption of state claims for EPA-approved herbicides would lift a huge weight from Bayer’s shoulders. The opposite outcome would pile on liabilities in thousands of pending lawsuits. Separately, June 4 marked the deadline for plaintiffs to opt out of a tentative $7.25 billion glyphosate settlement. The market is now watching to see how many claimants stayed in the deal; if too many exited, Bayer can walk away from the agreement.

The financial strain is already visible. Free cash flow in the first quarter of 2026 came in at minus €2.32 billion, driven largely by higher payments to resolve litigation over PCB and glyphosate. For the full year, Bayer forecasts cash outflows of roughly €5 billion for legal settlements, with free cash flow reaching as low as minus €2.5 billion. The operating business posted a decent first quarter — revenue rose 4.1 percent currency- and portfolio-adjusted to €13.4 billion, and adjusted EBITDA grew 9 percent — but those numbers are being consumed by legal costs.

Anderson did not mince words about the broader business environment in Germany, calling the country’s cost structure a “massive disadvantage.” Labor ancillary costs, bureaucracy, and energy prices are all too high, he said. The price of electricity in Germany is more than triple that on the Texas Gulf Coast and more than double that in China. “I’ve been here for three years and it simply isn’t getting any better,” Anderson told t-online. He struck a slightly more diplomatic tone toward Chancellor Friedrich Merz, crediting him with competence, but insisted Germany needs “a mission” to revive its inventor spirit.

The shares have shed 5.46 percent since the start of the year and 6.67 percent over the past 30 days, undercutting an impressive 12-month gain of 36.77 percent. The 52-week high of €49.93 from February now sits about 28 percent above current levels. With the 30-day annualized volatility near 37 percent, Bayer remains one of the most unpredictable large caps in the DAX. Until the Supreme Court rules and the fertilizer-threat picture becomes clearer, the stock is likely to remain stuck in a range defined by legal headlines and global trade routes — not by moving averages.